home / stock / sbtx / sbtx short
Short Information | Silverback Therapeutics Inc. (NASDAQ:SBTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 301,333 |
Total Actual Volume | 3,906,565 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 15,067 |
Average Short Percentage | 8.90% |
Is there a SBTX Short Squeeze or Breakout about to happen?
See the SBTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-08-2022 | $5.82 | $5.87 | $6.15 | $5.72 | 116,700 | 7,200 | 6.17% |
11-07-2022 | $6.05 | $5.81 | $6.135 | $5.8 | 158,815 | 3,771 | 2.37% |
11-04-2022 | $6.1 | $6.01 | $6.1 | $5.86 | 130,885 | 7,168 | 5.48% |
11-03-2022 | $6.2 | $6.06 | $6.41 | $6.05 | 94,203 | 3,257 | 3.46% |
11-02-2022 | $6.16 | $6.23 | $6.46 | $5.89 | 140,774 | 10,970 | 7.79% |
11-01-2022 | $6.27 | $6.15 | $6.32 | $6.13 | 47,771 | 4,648 | 9.73% |
10-31-2022 | $6.14 | $6.22 | $6.5 | $6.08 | 372,532 | 17,046 | 4.58% |
10-28-2022 | $5.82 | $6.14 | $6.15 | $5.63 | 206,823 | 13,656 | 6.6% |
10-27-2022 | $6.18 | $5.78 | $6.18 | $5.545 | 230,517 | 12,676 | 5.5% |
10-26-2022 | $6.12 | $6.14 | $6.4 | $6.08 | 290,154 | 13,145 | 4.53% |
10-25-2022 | $5.84 | $6.13 | $6.4 | $5.84 | 306,580 | 24,063 | 7.85% |
10-24-2022 | $5.75 | $5.83 | $5.97 | $5.51 | 198,243 | 8,404 | 4.24% |
10-21-2022 | $6.02 | $5.73 | $6.0299 | $5.45 | 187,348 | 20,175 | 10.77% |
10-20-2022 | $5.79 | $5.9 | $6.1201 | $5.75 | 595,079 | 42,524 | 7.15% |
10-19-2022 | $5.59 | $5.26 | $5.62 | $5.2 | 51,285 | 6,818 | 13.29% |
10-18-2022 | $5.35 | $5.62 | $5.73 | $5.35 | 456,062 | 25,720 | 5.64% |
10-17-2022 | $5.26 | $5.5 | $5.58 | $5.26 | 159,770 | 61,274 | 38.35% |
10-14-2022 | $5.11 | $5.24 | $5.24 | $5.04 | 55,583 | 11,045 | 19.87% |
10-13-2022 | $4.97 | $5.17 | $5.17 | $4.91 | 58,500 | 4,021 | 6.87% |
10-12-2022 | $5.24 | $5.03 | $5.245 | $4.96 | 48,941 | 3,752 | 7.67% |
News, Short Squeeze, Breakout and More Instantly...
Silverback Therapeutics Inc. Company Name:
SBTX Stock Symbol:
NASDAQ Market:
EURneffy positioned to be the first and only needle-free adrenaline option authorized for emergency treatment of allergic reactions (anaphylaxis) in Europe Positive CHMP opinion and recommendation for approval of a mixed application for marketing authorization based on comprehensi...
neffy ® (epinephrine nasal spray) New Drug Application (NDA) and CRL response under review by FDA with anticipated review completion by early October 2024 Response submitted for neffy Marketing Authorization Application (MAA) to EMA’s CHMP; CHMP...
CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by CHMP, and includes results from a repeat dose PK/PD study of neffy under NAC conditions and updated ...